Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 3,900,811
- Share change
- +124,014
- Total reported value
- $20,278,960
- Price per share
- $5.19
- Number of holders
- 30
- Value change
- +$545,423
- Number of buys
- 19
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
11%
|
3,056,680
|
$18,187,000 | — | 31 Mar 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.53%
|
150,000
|
$893,000 | — | 31 Mar 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
145,000
|
$866,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.34%
|
97,778
|
$584,000 | — | 31 Mar 2017 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.29%
|
83,958
|
$500,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.29%
|
81,507
|
$485,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
36,750
|
$219,000 | — | 31 Mar 2017 | |
| Destination Wealth Management |
13F
|
Company |
0.1%
|
29,656
|
$176,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
26,343
|
$157,000 | — | 31 Mar 2017 | |
| Family Manage LLC |
13F
|
Company |
0.06%
|
16,320
|
$97,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
14,961
|
$89,000 | — | 31 Mar 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
12,505
|
$74,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
10,574
|
$63,000 | — | 31 Mar 2017 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
4,014
|
$24,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,226
|
$19,000 | — | 31 Mar 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,050
|
$6,000 | — | 31 Mar 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
1,050
|
$6,000 | — | 31 Mar 2017 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
850
|
$5,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
797
|
$4,000 | — | 31 Mar 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
721
|
$4,000 | — | 31 Mar 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
469
|
$3,000 | — | 31 Mar 2017 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
376
|
$2,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
255
|
$2,000 | — | 31 Mar 2017 | |
| Creative Planning |
13F
|
Company |
0%
|
250
|
$1,000 | — | 31 Mar 2017 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
210
|
$1,000 | — | 31 Mar 2017 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
102
|
$1,000 | — | 31 Mar 2017 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q2 2017
As of 30 Jun 2017,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,900,811 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, BlackRock Inc., Artal Group S.A., BRIDGEWAY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, Destination Wealth Management, Family Management Corp, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
25
Q2 2017 holders
30
Holder diff
5
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.